Table 3.
Therapies of the 11 Patients with R.japonica Infection During Hospitalization, April 20, to November 20, 2021, Yichang, China
| Patient No. | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | |
| Main medication* | DO 100mg po q12h | DO 100mg po q12h | DO 100mg IV q12h + LVX 0.5g IV qd | DO 100mg IV q12h + MXF 0.4g IV q12h | DO 100mg IV q12h | DO 100mg IV q12h | DO 100mg po q12h | DO 100mg po q12h | DO 100mg po q12h | DO 100mg po q12h | DO 100mg po q12h |
| Steroid hormones | MP 0.7mg/kg/d IV×11d | HC 2mg/kg/d IV×20 d | MP 0.7mg/kg/d IV×9d | MP 0.7mg/kg/d IV×4d | None | DEX 0.2mg/kg/d IV ×14d | None | None | None | None | None |
| Vasopressors | Yes | Yes | Yes | Yes | Yes | None | None | None | None | None | None |
| Respiratory support | MV | MV | ECMO | MV | NC | HFNC | NC | NC | None | None | NC |
| CRRT | Yes | Yes | Yes | Yes | None | Yes | None | None | None | None | None |
| PE | Yes | Yes | Yes | None | None | None | None | None | None | None | None |
| Transfusion* | Yes | Yes | Yes | None | None | Yes | None | None | None | None | None |
Note: *Transfusion referred to the transfusion of blood components.
Abbreviations: DO, Doxycycline; po, per os; IV, Intravenous drip; q12h, every 12 hours; qd, every day; LVX, Levofloxacin; MXF, Moxifloxacin; ECMO, Extracorporeal membrane oxygenation; MP, Methylprednisolone; HC, Hydrocortisone; DEX, Dexamethasone; MV, Mechanical ventilation; HFNC, High-flow nasal cannula oxygen therapy; NC, Nasal catheter oxygen inhalation; CRRT, Continuous renal replacement therapy; PE, Plasma exchange.